Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical Infectious Diseases - Tập 63 Số 6 - Trang 754-762 - 2016
Flo ri an Wagenlehner1, Jack D. Sobel2, Paul Newell3, J. Armstrong3, Xiangning Huang4, Gregory G. Stone5, Katrina Yates3, Leanne Gasink6
1Justus-Liebig-University, Giessen, Germany
2Detroit Medical Center, Michigan
3AstraZeneca, Alderley Park, Cheshire
4AstraZeneca, Cambridge, United Kingdom
5AstraZeneca, Waltham, Massachusetts
6AstraZeneca, Wilmington, Delaware

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1001/jamainternmed.2013.9763

10.1016/j.jinf.2011.05.015

10.1038/nrurol.2010.190

10.1016/j.ijantimicag.2011.09.009

10.1007/s11908-013-0315-7

10.1007/s00345-013-1218-9

10.1038/nrmicro3432

10.1517/14656566.2013.778827

10.1038/nrurol.2015.199

Tandogdu, 2014, Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study, World J Urol, 32, 791

10.1186/s12879-015-1123-5

10.1186/s13054-014-0596-8

10.1016/S0163-4453(97)93194-7

10.1111/j.1469-0691.2012.03821.x

10.3949/ccjm.80a.12182

10.1016/j.ajic.2007.10.013

10.1093/jac/dkp018

10.4065/mcp.2010.0674

10.1186/s12879-015-1054-1

10.1128/AAC.02247-12

10.2147/CE.S40698

Actavis Inc. AVYCAZ (ceftazidime-avibactam) for injection, for intravenous use: prescribing information. Available at: http://pi.actavis.com/data_stream.asp?product_group=1957&p=pi&language=E . Accessed 18 December 2015.

10.1185/03007995.2012.748653

European Medicines Agency. Addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. London: EMA, 2013. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500153953.pdf . Accessed 18 December 2015.

US Food and Drug Administration. Guidance for industry on complicated urinary tract infections: developing drugs for treatment. Draft guidance. Available at: http://www.regulations.gov/contentStreamer?documentId=FDA-2012-D-0148-0002&attachmentNumber=1&disposition=attachment&contentType=pdf . Accessed 18 December 2015.

Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing. 22nd informational supplement: Wayne, PA: CLSI, 2012.

10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I

10.1002/sim.4780040211

10.1128/AAC.02894-14

10.1128/AAC.01896-13

10.1128/AAC.00548-15

10.1093/cid/ciw133

10.1016/S1473-3099(16)30004-4

10.1111/j.1464-410X.2005.05630.x

10.1128/AAC.00837-08

10.1128/AAC.01133-08

Grabe M , Bartoletti R , Bjerklund Johansen TE et al . Guidelines on urological infections. Available at: http://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf . Accessed 9 November 2015.

Shionogi Inc. DORIBAX (doripenem for injection), for intravenous use: prescribing information. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022106s015lbl.pdf . Accessed 18 December 2015.

10.1128/AAC.03579-14

10.1128/AAC.03267-14